321 related articles for article (PubMed ID: 25854375)
1. Histopathological evaluation of urothelial carcinomas in transurethral resection urinary bladder tumor specimens: eight years of single center experience.
Koyuncuer A
Asian Pac J Cancer Prev; 2015; 16(7):2871-7. PubMed ID: 25854375
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases.
Pan CC; Chang YH; Chen KK; Yu HJ; Sun CH; Ho DM
Am J Clin Pathol; 2010 May; 133(5):788-95. PubMed ID: 20395527
[TBL] [Abstract][Full Text] [Related]
3. Histopathologic Evolution of Urothelial Carcinoma Recurrence in Transurethral Resection of the Urinary Bladder:35 Consecutive Cases And Literature Review.
Koyuncuer A
Asian Pac J Cancer Prev; 2017 Feb; 18(2):459-463. PubMed ID: 28345830
[TBL] [Abstract][Full Text] [Related]
4. Papillary urothelial neoplasm of low malignant potential of the urinary bladder: clinicopathologic and outcome analysis from a single academic center.
Lee TK; Chaux A; Karram S; Miyamoto H; Miller JS; Fajardo DA; Epstein JI; Netto GJ
Hum Pathol; 2011 Nov; 42(11):1799-803. PubMed ID: 21777949
[TBL] [Abstract][Full Text] [Related]
5. CLINICO-PATHOLOGICAL PATTERN, CLASSIFICATION AND STAGING OF URINARY BLADDER CARCINOMAS--A FIVE YEARS EXPERIENCE AT A TERTIARY CARE HOSPITAL IN CENTRAL PUNJAB.
Naeem A; Naseem N; Anwar S; Butt S; Nagi AH
J Ayub Med Coll Abbottabad; 2015; 27(1):131-4. PubMed ID: 26182758
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
Chang WC; Chang YH; Pan CC
Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
[TBL] [Abstract][Full Text] [Related]
7. Measuring the dimension of invasive component in pT1 urothelial carcinoma in transurethral resection specimens can predict time to recurrence.
Hu Z; Mudaliar K; Quek ML; Paner GP; Barkan GA
Ann Diagn Pathol; 2014 Apr; 18(2):49-52. PubMed ID: 24370460
[TBL] [Abstract][Full Text] [Related]
8. Urinary cytology for the detection of urothelial carcinoma of the bladder--a flawed adjunct to cystoscopy?
Bolenz C; West AM; Ortiz N; Kabbani W; Lotan Y
Urol Oncol; 2013 Apr; 31(3):366-71. PubMed ID: 21414815
[TBL] [Abstract][Full Text] [Related]
9. CD 10 expression intensity in various grades and stages of urothelial carcinoma of urinary bladder.
Atique M; Abbasi MS; Jamal S; Khadim MT; Akhtar F; Jamal N
J Coll Physicians Surg Pak; 2014 May; 24(5):351-5. PubMed ID: 24848395
[TBL] [Abstract][Full Text] [Related]
10. Cytokeratin 20 immunocytochemistry on urine sediments: A potential low-cost adjunct to cytology in the diagnosis of low-grade urothelial carcinoma.
Wadhwa N; Diwaker P; Lotha N; Arora VK; Singh N
Cytopathology; 2017 Dec; 28(6):531-535. PubMed ID: 28940433
[TBL] [Abstract][Full Text] [Related]
11. Urothelial neoplasms of the urinary bladder occurring in young adult and pediatric patients: a comprehensive review of literature with implications for patient management.
Paner GP; Zehnder P; Amin AM; Husain AN; Desai MM
Adv Anat Pathol; 2011 Jan; 18(1):79-89. PubMed ID: 21169741
[TBL] [Abstract][Full Text] [Related]
12. Long-term Bladder and Upper Urinary Tract Follow-up Recurrence and Progression Rates of G1-2 Non-muscle-invasive Urothelial Carcinoma of the Bladder.
Golabesk T; Palou J; Rodriguez O; Parada R; Skrobot S; Peña JA; Villavicencio H
Urology; 2017 Feb; 100():145-150. PubMed ID: 27765584
[TBL] [Abstract][Full Text] [Related]
13. Urothelial tumours of the urinary bladder: a histopathological study of cystoscopic biopsies.
Vaidya S; Lakhey M; K C S; Hirachand S
JNMA J Nepal Med Assoc; 2013; 52(191):475-8. PubMed ID: 24907954
[TBL] [Abstract][Full Text] [Related]
14. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients.
Picozzi S; Ricci C; Gaeta M; Ratti D; Macchi A; Casellato S; Bozzini G; Carmignani L
J Urol; 2012 Dec; 188(6):2046-54. PubMed ID: 23083867
[TBL] [Abstract][Full Text] [Related]
15. PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata: associations with localized stage progression.
Inman BA; Sebo TJ; Frigola X; Dong H; Bergstralh EJ; Frank I; Fradet Y; Lacombe L; Kwon ED
Cancer; 2007 Apr; 109(8):1499-505. PubMed ID: 17340590
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of p63, p53 in urinary bladder carcinoma.
Koyuncuer A
Indian J Pathol Microbiol; 2013; 56(1):10-5. PubMed ID: 23924551
[TBL] [Abstract][Full Text] [Related]
17. A Novel Urine-Based Assay for Bladder Cancer Diagnosis: Multi-Institutional Validation Study.
Davis N; Shtabsky A; Lew S; Rona R; Leibovitch I; Nativ O; Cohen M; Mor Y; Lindner U; Glickman Y; Matzkin H; Tsivian A; Gofrit O; Yossepovitch O
Eur Urol Focus; 2018 Apr; 4(3):388-394. PubMed ID: 28753799
[TBL] [Abstract][Full Text] [Related]
18. Reduced immunohistochemical PTEN staining is associated with higher progression rate and recurrence episodes in non-invasive low-grade papillary urothelial carcinoma of the bladder.
Kulac I; Arslankoz S; Netto GJ; Ertoy Baydar D
Virchows Arch; 2018 Jun; 472(6):969-974. PubMed ID: 29368083
[TBL] [Abstract][Full Text] [Related]
19. [Experience in the use of confocal laser endomicroscopy for the diagnosis of bladder papillary tumors].
Shoaydarov MA; Martov AG; Andronov AS; Dutov SV; Pominalnaya VM
Urologiia; 2023 May; (2):99-106. PubMed ID: 37401712
[TBL] [Abstract][Full Text] [Related]
20. High-grade papillary urothelial carcinoma of the urinary tract: a clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic center.
Chaux A; Karram S; Miller JS; Fajardo DA; Lee TK; Miyamoto H; Netto GJ
Hum Pathol; 2012 Jan; 43(1):115-20. PubMed ID: 21820145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]